Introduction to Kidney Tumors



Introduction to Kidney Tumors


Satish K. Tickoo, MD

Victor E. Reuter, MD








The relationship of renal sinus soft tissues with renal parenchyma is depicted. Sinus fat invasion (pT3a) may occur not only at the medial aspect of kidney image, but also in the deeper “intrarenal” component of the sinus image.






This graphic shows the arrangement of renal vessels in the renal sinus. AJCC/TNM staging regards the invasion of the renal vein branches in the renal sinus image as equivalent to the main renal vein image invasion.


TERMINOLOGY


Abbreviations



  • Renal cell carcinoma (RCC), urothelial carcinoma (UC)


EPIDEMIOLOGY


Incidence



  • RCC accounts for approximately 2% of all cancers



    • In 2009, there were estimated 57,760 new cases of kidney and renal pelvic cancer in USA



      • In UK, more than 6,500 cases are reported per year


  • Incidence of RCC has increased substantially over the last 2 decades



    • Increased incidence, at least in part, is a result of improved diagnostic techniques


    • Most cases of RCC in larger medical centers are now incidentally detected, mostly on radiologic investigations for unrelated conditions


  • Compared to renal cortical tumors, carcinomas of renal pelvis and ureter are relatively uncommon



    • They constitute 0.1% and 0.07% of all cancers in men and women, respectively, in North America



      • Account for 4-5% of all urothelial tumors


      • Majority (> 90%) of these tumors are usual urothelial (transitional cell) carcinomas


      • The rest are tumors with aberrant histologies, squamous cell carcinomas being the most common of these


Ethnicity Relationship



  • Incidence varies among countries, with highest rates in North America and Scandinavia


  • In USA, incidence is equal among whites and blacks


Gender



  • RCCs and urothelial carcinomas of renal pelvis occur 2x more frequently in men than in women


Natural History



  • Renal cell tumors



    • In USA, close to 13,000 deaths due to RCC are reported each year


    • Worldwide, the disease results in > 100,000 deaths every year


    • Up to 30% of patients with RCC present with metastatic disease, and recurrence develops in 40% of patients treated for localized tumor


    • 5-year survival rates historically are approximately 40%; median overall survival in patients with metastasis is approximately 12 months



      • Recently, targeted therapies against various pathway molecules active in RCC have shown promising results


  • Renal pelvic and ureteric tumors



    • 5-year survival



      • > 99% for Ta


      • 91% for T1


      • 72% for T2


      • 40% for T3


      • 16% for patients with metastasis


Age Range



  • RCC and UC of upper tract show wide age spectrum



    • However, peak incidence in 6th and 7th decades of life


CLINICAL IMPLICATIONS


Anatomic Considerations: Renal Cell Tumors



  • Gerota fascia (renal fascia)



    • Layer of connective tissue encapsulating perirenal fat, and the kidney and adrenal within it



      • Anterior to this fascia is anterior pararenal space, which contains pancreas, transverse colon, and parts of duodenum


      • Surgeons typically remove the kidney along with its Gerota fascia



      • Microscopically, Gerota fascia does not have any distinctive features, other than ill-defined, somewhat compressed connective tissue


      • For practical purposes, tumors present at soft tissue margins of specimen are considered to invade Gerota fascia (pT4)


  • Protrusion vs. perinephric fat invasion



    • RCC frequently shows exophytic, often mushroomlike component protruding into perirenal fat



      • It is usually capped by well-defined smooth fibrous capsule


      • Unless tumor shows irregular extensions, incomplete pseudocapsule, or single cells invading fat, not regarded as extracapsular extension (pT3a)


  • Renal sinus



    • It constitutes extrarenal soft tissue lateral to imaginary vertical line joining medial-most aspects of upper and lower renal poles


    • Contains adipose tissue, lymphatics, veins, arteries, nerves, and pelvicalyceal system


    • Extends deep into kidney, while surrounding calyces (“intrarenal portion of sinus”)


    • Invasion of sinus fat or sinus veins may occur around pelvis or deep within “intrarenal portion of sinus” (pT3a)


    • Unlike that in the rest of the organ, the kidney lacks a renal capsule in sinus


  • Renal sinus vein and fat invasion



    • According to AJCC/TNM staging, sinus fat or extrarenal fat invasion assigned same pT stage (pT3a)


    • Similarly, invasion of muscular branches of renal vein in renal sinus and main renal vein invasion also assigned same pT stage (pT3a)


    • Careful evaluation reveals sinus fat or vein invasion in overwhelming majority of tumors > 7 cm in diameter



      • Smaller tumors located close to renal sinus also frequently show sinus vein or fat invasion


    • Current AJCC/TNM staging designates tumors > 10 cm confined to kidney as pT2b



      • However, probability of such large tumors limited to kidney is low and warrants close gross evaluation and adequate sampling to rule out extrarenal extension


    • Microscopic presence of large tumor masses in sinus veins, in spite of not being mentioned in gross description, usually suggests inadequate gross evaluation



      • Presence of intravenous tumor masses on microscopy may be considered equivalent to gross venous involvement not picked up on grossing


    • Sinus fat invasion may occur as direct tumor extension into fat or tumor present in veins penetrating through vessel wall



      • Some authors believe that penetration out of venous walls is main mechanism of sinus fat invasion


Anatomic Considerations: Renal Pelvic and Ureteric Tumors



  • Renal papillae are directly covered by urothelium, without underlying muscularis



    • Early invasion in area of renal papilla directly involves renal parenchyma (pT3)


    • On the other hand, invasion in pelvicalyceal system away from renal parenchyma often results in lower pT stage (pT1 or pT2)


  • Ureter does not contain muscularis mucosae, and muscularis (propria) often extends close to urothelium



    • Therefore, invasion in ureter more readily involves muscularis propria (pT2)


Intraoperative (Frozen Section) Evaluation: Main Indications



  • To determine whether the tumor is a renal cortical neoplasm or urothelial carcinoma of pelvicalyceal system



    • Distinction particularly important when partial nephrectomies are being contemplated



      • For urothelial carcinoma, partial or even total nephrectomy is usually not adequate or acceptable option


      • Standard surgical procedure for urothelial carcinoma is nephroureterectomy, ± resection of bladder cuff


      • For renal cortical neoplasms, no further intraoperative action may be needed


      • Specific intraoperative subtyping of cortical tumors is not required/necessary, as surgical management is not dependent on specific tumor type


  • To evaluate surgical margins, particularly in partial nephrectomies



    • Positive “frozen section” margins will often lead to additional surgical resection for cortical tumors


Staging Issues: Renal Cortical Tumors



  • Renal cortical tumors confined to kidney assigned stages pT1 or pT2 by AJCC/WHO



    • Specific maximum size of primary tumors reported as important prognostic factor in many studies, but not always on multivariate analysis



      • Size as a continuous variable more often shown to have impact on clinical outcome


      • However, specific size limits are considered useful for purposes of management and clinical trial protocols


      • Therefore, specific sizes used in TNM staging


  • Soft tissue or vascular spread beyond kidney (pT3) recognized as major prognostic factor



    • Before the 6th edition of TNM/AJCC staging system (2002), no mention was made of renal sinus fat or renal vein branch invasion


    • Multiple recent studies report prognostic significance of renal sinus fat or muscular branches of renal vein invasion



      • Currently, sinus fat and muscular renal sinus vein invasion equated with perinephric fat and
        main renal vein invasion, respectively, for staging purposes


  • Adrenal gland invasion

Jul 6, 2016 | Posted by in PATHOLOGY & LABORATORY MEDICINE | Comments Off on Introduction to Kidney Tumors

Full access? Get Clinical Tree

Get Clinical Tree app for offline access